Valuation: Samsung Biologics Co.,Ltd.

Capitalization 76,241B 51.31B 44.38B 40.18B 38.58B 70.36B 4,712B 73.47B 475B 190B 2,258B 193B 188B 8,096B P/E ratio 2026 *
44.9x
P/E ratio 2027 * 35.6x
Enterprise value 73.09B 49.19M 42.54M 38.52M 36.98M 67.45M 4.52B 70.42M 456M 182M 2.16B 185M 181M 7.76B EV / Sales 2026 *
13.5x
EV / Sales 2027 * 10.3x
Free-Float
25.44%
Yield 2026 *
-
Yield 2027 * 0.03%
1 day+8.64%
1 week+64.70%
Current month+64.70%
1 month+64.70%
3 months+64.70%
6 months+64.70%
Current year+64.70%
1 week 1,000,000
Extreme 999999.9999
1,669,000
1 month 1,000,000
Extreme 999999.9999
1,669,000
Current year 1,000,000
Extreme 999999.9999
1,669,000
1 year 1,000,000
Extreme 999999.9999
1,669,000
3 years 1,000,000
Extreme 999999.9999
1,669,000
5 years 1,000,000
Extreme 999999.9999
1,669,000
10 years 192,960.76
Extreme 192960.7607
1,669,000
Manager TitleAgeSince
Chief Executive Officer 64 08/12/2020
Director of Finance/CFO 58 13/03/2025
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Chairman 64 08/12/2020
Director/Board Member 72 28/03/2022
Director/Board Member 67 19/03/2020
Change 5d. change 1-year change 3-years change Capi.($)
+8.64%+64.70%+64.70%+64.70% 51.31B
-2.87%-0.76%+11.32%-1.84% 78.5B
-1.98%+3.82%+31.82%+222.78% 56.77B
-0.15%-0.33%-44.17%-50.33% 49.23B
-0.98%+0.03%+30.82%-30.41% 27.6B
-6.87%+4.10%+52.88%-62.41% 21.26B
-1.55%-2.76%+39.42%+25.49% 19.37B
+5.86%-2.17%+106.32%+96.11% 17.42B
-1.29%-4.56%+22.73%+57.33% 14.22B
-0.56%-2.13%+89.22%+508.74% 12.83B
Average -0.15%-1.57%+40.51%+83.02% 34.85B
Weighted average by Cap. -0.07%-1.01%+28.40%+59.36%

Financials

2026 *2027 *
Net sales 5,396B 3.63B 3.14B 2.84B 2.73B 4.98B 334B 5.2B 33.65B 13.44B 160B 13.63B 13.34B 573B 6,992B 4.71B 4.07B 3.69B 3.54B 6.45B 432B 6.74B 43.6B 17.42B 207B 17.66B 17.29B 742B
Net income 1,815B 1.22B 1.06B 957M 919M 1.68B 112B 1.75B 11.32B 4.52B 53.76B 4.59B 4.49B 193B 2,244B 1.51B 1.31B 1.18B 1.14B 2.07B 139B 2.16B 13.99B 5.59B 66.46B 5.67B 5.55B 238B
Net Debt -3,156B -2.12B -1.84B -1.66B -1.6B -2.91B -195B -3.04B -19.68B -7.86B -93.45B -7.97B -7.8B -335B -3,885B -2.61B -2.26B -2.05B -1.97B -3.59B -240B -3.74B -24.22B -9.68B -115B -9.81B -9.6B -412B
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
Date Price Change Volume
05/03/26 1,647,000.00 +8.64% 70,178
04/03/26 1,516,000.00 -9.82% 83,414
03/03/26 1,681,000.00 -5.46% 81,261
27/02/26 1,778,000.00 +0.68% 97,725
26/02/26 1,766,000.00 +2.20% 88,413
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
1,647,000.00KRW
Average target price
2,253,934.38KRW
Spread / Average Target
+36.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock